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• Evaluate and compare how two large tertiary hospitals 
have provided prompt evidence based medical therapy 
to Blacks, Latinx, and Natives, in comparison to 
Caucasians pertaining to hypertensive emergency, non-
ST segment elevation myocardial infarction (NSTEMI), 
and cerebrovascular accident (CVA)
Patient Population
• The total number of patients in the study was 4,308.
• Breakdown of primary clinical diagnosis categories by 
order of most prevalent: CVA (n=1,858), NSTEMI 
(1,695), hypertensive emergency (n=8)
• Total population heavily consisted of White or 
Caucasian (n=3,359) which was 94% of the racial 
groups.
• Total Hispanic or Latino population (n=207) was 4.8% of 
ethnicity groups.
Primary and Secondary Outcomes:
NSTEMI: 
• Similar ordering rates of ECG 12 lead and troponin, (98-
100%). American Indian/Alaska Native group had 
longest time elapse before ordering either. 
• Aspirin ordering rates were  18% for American 
Indian/Alaska Native, 43% for Black/African American, 
50-51% for the remaining three groups .
Hypertensive Emergency: 
• No data for either Black/African American or American 
Indian/Alaska Native groups. 
• Emergent anti-hypertensive agent ordering rates were 
100% for all groups, with White/Caucasian and Not 
Hispanic/Latino groups having shortest time-to anti-
hypertensive agent being ordered.
• Achieving average BP <160/110 mmHg in the first 24 
hours favored the Not Hispanic/Latino group with the 
highest rate of 25%, followed by 13% for 
White/Caucasian and  0% for Hispanic/Latino.
CVA:
• Alteplase ordering rates were lowest in the American 
Indian/Alaska Native group (6%) followed by the 
Black/African American group (11%) which also had the 
longest time elapse before ordering (76 minutes).
• American Indian/Alaska Native population had lowest 
ordering rates for brain non-contrast CT or MRI at 41% 
and the lowest ordering rates of key labs/diagnostics 
outside of brain imaging at  6%.
Limitations:
• Descriptive study – no statistical analysis performed 
• Racial and ethnic identification inaccuracy cannot be 
ruled out as data was pulled from Epic.
• Unidentified variables may have altered the choice of 
therapy from providers (e.g., formulary changes)
1. N ational A cadem ies of Sciences, Engineering , and  M edicine; H ealth  and  M edicine  D iv ision ; Board  on  Population  H ealth  and  Pub lic H ealth  Practice ; 
B aciu  A , N egussie  Y, G eller A , et a l., eds. C om m unities in  A ction: Pathw ays to  H ealth  Equ ity. W ash ington  (D C ): N ational A cadem ie s Press (U S); 
January 11 , 2017.
2 . A m erican  Society  of H ealth-System  Pharm acists. A SH P statem ent on  racia l and  ethn ic d isparities in  health  care . A m  J H ealth-Syst Pharm . 2008; 
65:728–33. 
3 . C enters for D isease  C ontro l and  Prevention . U nderly ing  C ause  of D eath , 1999–2018. C D C  W O N D ER  O nline  D atabase. Atlanta , G A : C enters for 
D isease  C ontro l and  Prevention; 2018. A ccessed  M arch  12, 2020.
4 . 2014 A H A /AC C  G uide line  for the  M anagem ent of Patients W ith  N on–ST-E levation  A cute  C oronary Syndrom es
5. G uidelines for the  Early  M anagem ent of Patients W ith  A cute  Ischem ic Stroke: 2019 U pdate  to  the  2018 G u ide lines for the  Early  M anagem ent of 
A cute  Ischem ic Stroke: A  G u ide line  for H ealthcare  Professionals From  the  A m erican  H eart A ssociation/A m erican  Stroke  
6 . 2017 AC C /A H A /A A PA /A B C /AC PM /AG S/A PhA /A SH /A SPC /N M A /PC N A  G uideline  for the  Prevention , D etection , Eva luation , and  M anagem ent of H igh  
B lood  Pressure  in  A du lts: A  Report o f the  A m erican  C o llege  of C ard io logy/A m erican  H eart A ssociation  Task Force  on  C lin ica l Practice  G u ide lines
Health & Services
• Health disparity is a sum of differences in healthcare 
seen in underserved populations of the United States. 1
• Differences include incidence, prevalence, mortality, 
burden of disease, and other adverse health 
conditions
• According to ASHP, health disparities continue to be a 
major public health problem confronting the U.S. 
health care systems. 2
• Evidence suggests that health disparities can be in part 
due to differences in the quality of care for different 
racial and ethnic groups. 2
• All the different disparity factors have been shown to 
lead to different health outcomes that do not favor 
Black, Latinx, and Native American populations.
• ASHP believes health-system pharmacists have both a 
professional and moral obligation to take part in 
initiatives that work towards erasing any racial and 
ethnic disparities in healthcare. 2
• Examples of ways pharmacists can make an impact are:
• Increase awareness among fellow caregivers
• Ensure effective communication by volunteering for 
leadership roles
• Enforce consistency of using evidence-based 
therapy for all patients
• Analyze data for outcomes sorted by racial 
minorities
• Per ASHP there are three general principles that serve 
as guides for pharmacist to help erase healthcare 
disparities: 2
1. All patients have the right to high-quality care, by 
taking leadership roles pharmacists can partake in 
initiatives to increase access to care.
2. Medication-use practices should reflect knowledge 
of, sensitivity to, and respect for the race and 
culture of the patient.
3. Health-system pharmacists have a vital role to play 
in eliminating racial and ethnic disparities in health 
care.
Methodology
• Institutional Review Board (IRB) – approved 
• Double center, observational, descriptive-analysis, 
retrospective review, spanning 51 months (January 1st, 
2017, to March 31st, 2021), of adults presenting to ED at 
either of the two large tertiary hospitals.
• Inclusion criteria
• Black, Latinx, Native American, and Caucasian adults 
(> 18 years old) presenting to the ED with primary 
diagnosis of NSTEMI, hypertensive emergency, or CVA. 
• Exclusion criteria
• < 18 years old; patients not meeting the pre-specified 
race/ethnicity criteria; primary diagnosis outside of 
hypertensive emergency, NSTEMI, or CVA
• Establish statistical analysis to determine statistically 
significant differences among the variables
• Data collection on race and ethnicity needs to 
improve to make certain that data capturing is accurate 
and consistent.
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Objective
• Determine what differences there may be in providing 
various non-medication/medication interventions and 
time-to-intervention order placement after arrival to 
the emergency department (ED)
Results
Conclusions
• Differences in care were present, with more 
unfavorable trends seen in the American Indian/Alaska 
Native group.
• Data inconsistencies made reliability of results 
uncertain. This also made statical analysis challenging.
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